TECHNOLOGY

BRAND STORY ABOUT EXOSOME TECHNOLOGY PRODUCT

Research results

Entr® technology Research results

EXOSOME Technology Entr®

discovered through the change of conception

41 domestic and foreign patents related to Entr® technology

EXONIA Exosome's Entr® technology has applied for and registered 7 domestic technology patents,,

19 overseas technology patents, 4 domestic design patents, 6 domestic trademark patents, and 4 domestic device patents.

Entr® technology listed in overseas journals

EXONIA Exosome extraction technology Entr® method published as SCI-level thesis

Famous journals such as Nature materials evaluated the excellence of Entr® technology

Papers on induced pluripotent stem cell
generation technology by ultrasound

Biomaterials. vol. 143, p65~78(2017)

2017 1F 10.542

Cell reprogramming induced by EXONIA exosomes (liposome) is simple, safe and efficient, enabling clinical application using autologous stem cells.

Papers on direct cross differentiation
technology by ultrasound

ACS NANO. vol. 12, p.2531~2538 (2018)

2018 1F 14.588

The cell reprogramming strategy induced by physical stimuli is a method that can induce large quantities simply, fast and at low cost and is safe, so it can provide a new paradigm in clinical applications.

Papers on fibroblast-derived direct cross-differentiated
human endothelial cell generation technology by ultrasound

Journal of Molecular and Cellular Cardiology. vol. 126, p.118~128 (2019)

2019 1F 5.863

Our data show that cell reprogramming induced by physical stimuli can be used as a unique therapeutic agent because it shows high efficiency and safety